---
status: "🟡 Draft"
category: "grant"
type: "solution-summary"
due: "2026-04-08"
priority: "P0-Critical"
tags: [ARPA-H, Delphi, grant, solution-summary, quantum-biology]
created: "2026-03-22"
updated: "2026-03-22"
---
# ARPA-H DELPHI — 6-PAGE SOLUTION SUMMARY

> [!target] SUBMISSION TARGET: ARPA-H Delphi — April 8, 2026 | Status: DRAFT | Completion: ~40%

> PI: [Name] | Co-PI: Alessandra Lanzara (UCB Physics) | Collaborator: Markus Buehler (MIT DMSE)

---

## PAGE 1 — EXECUTIVE SUMMARY

### Problem

Current cancer diagnostics miss early-stage metabolic shifts; aging biomarkers lack mechanistic grounding. Both fields operate in silos despite sharing a common quantum-biological substrate. No existing platform unifies cancer and aging detection through a single mechanistic framework.

### Insight

Cancer **amplifies** and aging **decoheres** the same four quantum protection architectures:

1. **FMO excitonic coherence** — wavelike energy transfer in light-harvesting analogs
2. **Enzyme quantum tunneling** — hydrogen and electron tunneling in metabolic enzymes
3. **Mitochondrial ETC quantum transfer** — electron tunneling through respiratory chain complexes
4. **Cryptochrome spin coherence** — radical pair spin dynamics in flavoproteins

These architectures are not independent — they share metabolite substrates (NADH, FAD, ATP, GSH) that serve as measurable indicators of quantum protection status.

### Solution

**Probius QES** label-free vibrational spectroscopy captures NADH/FAD/ATP/GSH fingerprints from 2–4 µL plasma (finger-stick). These four metabolite signatures encode opposing cancer↑ / aging↓ trajectories that are integrated into a **Quantum Protection Index (QPI)** — a composite diagnostic score.

### Impact

A unified quantum-protection diagnostic platform enabling:
- **Earlier cancer detection** through metabolic quantum amplification signatures
- **Mechanistic aging quantification** through decoherence trajectory tracking
- **Single finger-stick sample** — point-of-care, population-scalable
- **Longitudinal monitoring** — track quantum protection status over time

### Team

| Member | Institution | Role |
|---|---|---|
| PI | UCB / UCSF | Quantum biology integration, QPI development |
| Alessandra Lanzara | UCB Physics | Ultrafast mid-IR/THz spectroscopy, ground-truth validation |
| Markus Buehler | MIT DMSE | ScienceClaw × Infinite swarm AI, computational modeling |
| Clinical Partners | UCSF | Clinical translation, cohort recruitment, regulatory |

---

## PAGE 2 — TECHNICAL APPROACH

### Architecture Overview

The quantum protection framework rests on four experimentally validated architectures:

| Architecture | Mechanism | Key Evidence | Cancer Signature | Aging Signature |
|---|---|---|---|---|
| 1. FMO Coherence | Excitonic energy transfer | Engel 2007 | Enhanced coherence | Shortened lifetime |
| 2. Enzyme Tunneling | H-transfer / e⁻ tunneling | Moser-Dutton | Accelerated tunneling | Impaired tunneling |
| 3. ETC Transfer | Mitochondrial e⁻ transport | Complex I studies | Warburg amplification | NAD+ depletion |
| 4. Spin Coherence | Radical pair dynamics | Hore-Mouritsen 2016 | ROS-altered spin states | Oxidative disruption |

### Quantum Protection Index (QPI) Model

$$QPI = w_1 \cdot f(NADH) + w_2 \cdot f(FAD) + w_3 \cdot f(ATP) + w_4 \cdot f(GSH)$$

- QPI > 0 → Cancer trajectory | QPI < 0 → Aging trajectory | QPI ≈ 0 → Homeostasis
- Full mathematical framework: [[01-Core-Thesis/Quantum-Protection-Index-QPI-Model]]

### Measurement Strategy

**Probius QES** operating principles:
- Label-free vibrational spectroscopy on 2–4 µL plasma
- Spectral targets: NADH (340/460 nm), FAD (450/525 nm), GSH (thiol vibrational modes), ATP (phosphate stretches)
- Sample-to-result: < 15 minutes from finger-stick

### Top 5 Candidate Biomarkers

Selected for maximum architecture coverage and Probius readout strength — see [[00-Flight-Deck/Top-5-Delphi-Candidates]]:

1. **GSH** — 4/4 architectures, direct QES, keystone metabolite
2. **NADH** — 3/4 architectures, direct QES, primary energy currency
3. **Complex I** — 3/4 architectures, direct via NADH, electron tunneling site
4. **NRF2** — 3/4 architectures, indirect via GSH, master regulator
5. **FAD** — 3/4 architectures, direct QES, spin coherence cofactor

### Validation Pipeline

```
Finger-stick plasma → QES measurement → Spectral decomposition →
QPI scoring → Clinical correlation → Longitudinal tracking
```

### Swarm AI Integration

ScienceClaw × Infinite agents (MIT Buehler lab) provide:
- Automated literature mining across quantum biology corpus
- Hypothesis generation with testability scores
- Architecture mapping of novel candidate metabolites
- Tunneling geometry MD simulations

---

## PAGE 3 — EXPECTED OUTCOMES & MILESTONES

### Year 1: Foundation & Validation

- Establish QES baseline signatures for top 5 biomarkers in healthy controls (n=50)
- Validate cancer↑ signatures in matched tumor/normal pairs (n=30)
- Deploy swarm artifact ingestion pipeline
- Calibrate QES against Lanzara ultrafast spectroscopy ground truth

### Year 2: Cohort Expansion & QPI Refinement

- Prospective aging cohort (n=100, ages 25–85) for QPI age-correlation
- Cross-validate QES with Lanzara ultrafast pump-probe measurements
- Refine QPI algorithm — optimize weights, test architecture sub-indices
- Publish QPI framework and initial clinical correlations

### Year 3: Integration & Translation

- Integrated cancer + aging diagnostic prototype
- Clinical pilot (n=200) with blinded evaluation
- Regulatory pathway assessment (510(k) or De Novo classification)
- Multi-site reproducibility study
- Publication of full QPI validation results

### Key Milestones

| Quarter | Milestone | Deliverable | Go/No-Go Criteria |
|---|---|---|---|
| Q1 Y1 | QES calibration complete | Calibration dataset | QES-spectroscopy r² > 0.7 |
| Q2 Y1 | Healthy baseline established | n=50 reference profiles | All 4 metabolites detectable |
| Q3 Y1 | Cancer signatures confirmed | n=30 tumor/normal pairs | ≥3/5 biomarkers show cancer↑ |
| Q4 Y1 | Swarm pipeline operational | Automated artifact flow | ≥10 validated artifacts/month |
| Q1 Y2 | Aging cohort recruited | n=100 enrolled | Age distribution 25–85 |
| Q2 Y2 | QPI v1.0 released | Algorithm + weights | AUC > 0.75 on training set |
| Q3 Y2 | Cross-validation complete | QES vs Lanzara concordance | Concordance > 80% |
| Q4 Y2 | QPI publication submitted | Manuscript | Peer review initiated |
| Q1 Y3 | Prototype device | Integrated QES + QPI | Sample-to-score < 20 min |
| Q2 Y3 | Clinical pilot launched | n=200 enrolled | IRB approved, sites active |
| Q3 Y3 | Regulatory strategy finalized | FDA pre-submission | Classification determined |
| Q4 Y3 | Multi-site validation | ≥2 sites | Inter-site CV < 15% |

---

## PAGE 4 — TEAM & CAPABILITIES

> [!info] DRAFT — Complete team bios and capabilities

**[Draft team bios and capabilities — Lanzara, Buehler, PI, clinical partners]**

### Principal Investigator
- Quantum biology integration
- QPI model development and validation
- Cross-institutional coordination

### Alessandra Lanzara (Co-PI, UCB Physics)
- Ultrafast mid-IR and THz spectroscopy
- Ground-truth coherence lifetime measurements
- UCB-UCSF $50K seed grant (active)

### Markus Buehler (Collaborator, MIT DMSE)
- ScienceClaw × Infinite swarm AI platform
- Computational tunneling geometry modeling
- Materials-to-biology translation

### UCSF Clinical Partners
- Cohort recruitment and clinical phenotyping
- Biospecimen collection and processing
- Regulatory and translational expertise

### Institutional Resources
- UCB: ultrafast spectroscopy facility, BSL-2 labs
- MIT: high-performance computing, AI infrastructure
- UCSF: clinical research infrastructure, biobank

---

## PAGE 5 — BUDGET JUSTIFICATION

> [!info] DRAFT — Complete budget breakdown

**[Budget breakdown by year and category]**

| Category | Year 1 | Year 2 | Year 3 | Total |
|---|---|---|---|---|
| Personnel | | | | |
| Equipment | | | | |
| Supplies (QES cartridges, reagents) | | | | |
| Travel (cross-site coordination) | | | | |
| Participant costs | | | | |
| Indirect costs | | | | |
| **Total** | | | | |

---

## PAGE 6 — REFERENCES & APPENDICES

> [!info] DRAFT — Complete references and appendices

**[Key references from literature notes]**

1. Engel GS et al. *Nature* 446:782-786 (2007) — FMO quantum coherence
2. Cao J et al. *Sci Adv* 6:eaaz4888 (2020) — Quantum biology review
3. Hore PJ, Mouritsen H. *Annu Rev Biophys* 45:299-344 (2016) — Radical pair magnetoreception
4. Yoshino J et al. *Cell Metab* 27:513-528 (2018) — NAD+ intermediates in aging
5. Moser CC, Dutton PL. *Biochim Biophys Acta* series — Electron tunneling in bioenergetics

**[Appendix items]**

- A: QPI mathematical framework (full derivation)
- B: Probius QES technical specifications
- C: Lanzara spectroscopy protocol
- D: ScienceClaw agent architecture
- E: Letters of support

---

## Submission Checklist

- [x] Pages 1–3 scaffolded with content
- [ ] Pages 4–6 content drafted
- [ ] Internal review / red-team pass
- [ ] Co-PI review (Lanzara)
- [ ] Final polish and format check (6-page limit)
- [ ] **SUBMIT — April 8, 2026**

## Links

- [[01-Core-Thesis/Core-Thesis]]
- [[01-Core-Thesis/Quantum-Protection-Index-QPI-Model]]
- [[00-Flight-Deck/Top-5-Delphi-Candidates]]
- [[03-Grants/UCB-UCSF-Seed-Grant]]
- [[03-Grants/Executive-Summary]]
- [[00-Flight-Deck/Red-Team-Review-Checklist]]
